$AYI

ACUITY INC. (DE)

AlphAI earnings readFiscal Q4 2026 and Fiscal 2026 · OCT 1Solid Execution Delivers Net Sales Growth, Improved Operating Performance, and Strong Cash FlowVerdict: solid

Reads like this one publish minutes after the filing lands on EDGAR. Get them as JSON over the API or inside your AI agent over MCP.

1
3
1

No SEC Form 4 filings for $AYI in the last 30 days.

See all $AYI insider activity →
High

Company Guidance Roundup: Nike, Acuity Issue New Guidance on Oct

Nike (NKE) provided fiscal 2027 adjusted EPS guidance of $1.15 to $1.35. Acuity (AYI) issued fiscal 2026 adjusted EPS guidance of $20.50 to $22.00 and fiscal 2027 EPS and revenue guidance of $20.50 to $22.00 and $4.7B to $4.9B, respectively. Both companies' guidance is based on their estimates.

Company News for Oct 2, 2026

Accenture's (ACN) shares rose 15.8% after beating Q4 earnings estimates. Acuity (AYI) fell 3.4% missing revenue estimates. McKesson (MCK) gained 5.3% after reaffirming fiscal 2027 EPS guidance. Progress Software (PRGS) dropped 8.5% after missing Q3 revenue estimates.

Stocks making the biggest moves midday: Accenture, Synopsys, United Therapeutics, Vicor and more

Accenture rose 18% after Q4 revenue of $18.7B beat estimates. McCormick's Q3 results topped expectations but shares fell 2% amid Unilever's acquisition. McKesson gained 4% on reaffirmed guidance and a CVS Health partnership. United Therapeutics climbed 6% after a court ruling, while Liquidia dropped 15%. Constellation Energy gained 3% on a 20-year Amazon deal. Synopsys jumped 8% with 2027 revenue targets. Sigma Lithium slid 16% after halting production.

AYI sentiment & insider activity

Over the past 7 days, AlphAI's AI scored 5 news stories mentioning AYI (ACUITY INC. (DE)). Coverage has been balanced: 1 bullish, 3 neutral, and 1 bearish.

Recent AYI coverage spans earnings and market movers.

What's driving AYI

AlphAI scores every news story that mentions AYI with an AI model for sentiment and relevance, and aggregates insider trades from ACUITY INC. (DE)'s SEC EDGAR Form 4 filings. Figures refresh continuously.

News on $AYI

Score
$ACNHighAI 8/10

Company News for Oct 2, 2026

Accenture's (ACN) shares rose 15.8% after beating Q4 earnings estimates. Acuity (AYI) fell 3.4% missing revenue estimates. McKesson (MCK) gained 5.3% after reaffirming fiscal 2027 EPS guidance. Progress Software (PRGS) dropped 8.5% after missing Q3 revenue estimates.

$ACNMed

Stocks making the biggest moves midday: Accenture, Synopsys, United Therapeutics, Vicor and more

Accenture rose 18% after Q4 revenue of $18.7B beat estimates. McCormick's Q3 results topped expectations but shares fell 2% amid Unilever's acquisition. McKesson gained 4% on reaffirmed guidance and a CVS Health partnership. United Therapeutics climbed 6% after a court ruling, while Liquidia dropped 15%. Constellation Energy gained 3% on a 20-year Amazon deal. Synopsys jumped 8% with 2027 revenue targets. Sigma Lithium slid 16% after halting production.

Acuity Brands (NYSE:AYI) Misses Q3 CY2026 Revenue Estimates

Acuity Brands (NYSE: AYI) reported Q3 CY2026 revenue of $1.24B, up 2.9% YoY but below estimates. Non-GAAP EPS of $5.77 beat expectations by 3.8%. The company highlighted growth in sales and operating margins, with long-term revenue growth at 6% CAGR. Analysts expect 4.9% revenue growth over the next 12 months.

$AYIHighAI 8/10

Acuity stock rises 2% on fourth-quarter earnings beat

Acuity Inc. (AYI) reported Q4 earnings of $5.77 per share, beating estimates by $0.11, but revenue of $1.24B missed expectations. Shares rose 2.23% in pre-market trading. Full-year sales increased 7% to $4.64B, with adjusted EPS up 11% to $19.90. The Intelligent Spaces segment grew 17% YoY, while Lighting segment sales declined 0.4% YoY.

Related tickers